ANGKA KETAHANAN HIDUP 3 TAHUN PASIEN KARSINOMA NASOFARINGS YANG MENDAPAT

NONCONCURRENT CHEMOTHERAPY 42
DI BAGIAN TELINGA HIDUNG TENGGOROK – KEPALA LEHER RSUP DR. SARDJITO PADA TAHUN
2008-2010
RYAN FERALDY HAROEN
Universitas Gadjah Mada, 2014 | Diunduh dari http://etd.repository.ugm.ac.id/

DAFTAR PUSTAKA

Ali, M Y. 1965. “Histology of the Human Nasopharyngeal

Mucosa.” Journal of Anatomy 99 (Pt 3) (July): 657–
72.
Angianto, Alexander Randy. 2010. “Disease Free Survival
Rate Pada Penderita Karsinoma Nasofarings Yang
Mendapat Terapi Fotodinamik” (Skripsi). Universitas
Gadjah Mada, Yogyakarta.
Barnes L., Eveson J.W., Reichart P., Sidransky D.
2005.”World Health Organization Classification of
Tumours: Pathology and Genetics of Head and Neck
Tumours”. IARC Press: Lyon. ISBN 92 832 2417 5.
Chan, A T C, P M L Teo, dan R K Ngan. 2002. “Concurrent
Chemotherapy-Radiotherapy Compared With
Radiotherapy Alone in Locoregionally Advanced
Nasopharyngeal Carcinoma: Progression-Free Survival
Analysis of a Phase III Randomized Trial”. J Clin
Oncol; 20:2038-2044.
Chan, A T C, P M L Teo, dan P J Johnson. 2002. “Review
Nasopharyngeal Carcinoma” (February).
doi:10.1093/annonc/mdf179.
Chan, Anthony T C. 2011. “Current Treatment of
Nasopharyngeal Carcinoma”. European Journal of
Cancer (Oxford, England : 1990) 47 Suppl 3
(September): S302–3. doi:10.1016/S0959-
8049(11)70179-4.
http://www.ncbi.nlm.nih.gov/pubmed/21943991.
Chen, Chi-Long dan Mow-Ming Hsu. 2000. “Second primary
epithelial malignancy of nasopharynx and nasal
cavity after successful curative radiation therapy
of nasopharyngeal carcinoma”. Human Pathology 31
(2) (February): 227-232.
Fawcett, Don W. 1994. “A Textbook of Histology Twelfth
Edition”. New York: Chapman & Hall.
Feng, Bing-Jian. 2013. “Chapter 3 Descriptive,
Environmental and Genetic Epidemiology of
Nasopharyngeal Carcinoma © 2013 Copyright Landes
Bioscience and Springer. Not for Distribution” 3:
23–41.
Fles, Renske, Maarten A Wildeman, Beni Sulistiono,
Sofia Mubarika Haryana, and I Bing Tan. 2010.
“Knowledge of General Practitioners About
Nasopharyngeal Cancer at the Puskesmas in
Yogyakarta, Indonesia”: 1–6. doi:10.1186/1472-6920-
10-81.
 ANGKA KETAHANAN HIDUP 3 TAHUN PASIEN KARSINOMA NASOFARINGS YANG MENDAPAT
NONCONCURRENT CHEMOTHERAPY 43
DI BAGIAN TELINGA HIDUNG TENGGOROK – KEPALA LEHER RSUP DR. SARDJITO PADA TAHUN
2008-2010
RYAN FERALDY HAROEN
Universitas Gadjah Mada, 2014 | Diunduh dari http://etd.repository.ugm.ac.id/

Fortuna, Gulio, dan Michele D Mignogna. 2011. ”Oral

Field Cancerization”. CMAJ (October 4) 183 (14).
DOI: 10.1503/cmaj.110172.
Hutajulu, Susanna H, Sagung R Indrasari, Luh P L
Indrawati, Ahmad Harijadi, Sylvia Duin, Sofia M
Haryana, Renske D M Steenbergen, Astrid E Greijer,
and Jaap M Middeldorp. 2011. “Epigenetic Markers
for Early Detection of Nasopharyngeal Carcinoma in
a High Risk Population”: 1–9. doi:10.1186/1476-
4598-10-48.
Jemal, Ahmedin, Freddie Bray, and Jacques Ferlay. 2011.
“Global Cancer Statistics” 61 (2): 69–90.
doi:10.3322/caac.20107.Available.
Khoo, Alan Soo, and Kin Choo Pua. 2013. “Chapter 1
Diagnosis and Clinical Evaluation of Nasopharyngeal
Carcinoma © 2013 Copyright Landes Bioscience and
Springer. Not for Distribution” 1: 1–9.
Kim, John. 2013. “Chapter 9 Radiotherapu of NPC:
Current Strategies and Prespectives © 2013
Copyright Landes Bioscience and Springer. Not for
Distribution” 9: 125–148.
Lee, Nancy Y, Qiang Zhang, David G Pfister, John Kim,
Adam S Garden, James Mechalakos, Kenneth Hu, et al.
2012. “Addition of Bevacizumab to Standard
Chemoradiation for Locoregionally Advanced
Nasopharyngeal Carcinoma (RTOG 0615): a Phase 2
Multi-Institutional Trial”. The Lancet Oncology 13
(2) (February): 172–80. doi:10.1016/S1470-
2045(11)70303-5.
http://www.ncbi.nlm.nih.gov/pubmed/22178121.
Liebowitz, D. 1994. “Nasopharyngeal carcinoma: the
EbsteinBarr virus association”. Seminars in
Oncology 21(3):376-381.
Nicholls, John, and Gerald Niedobitek. 2013.
“Histopathological Diagnosis of Nasopharyngeal
Carcinoma : Looking Beyond the Blue Book © 2013
Copyright Landes Bioscience and Springer. Not for
Distribution”: 10–22.
O’Sullivan, B, R B Rumble, and P Warde. 2012.
“Intensity-Modulated Radiotherapy in the Treatment
of Head and Neck Cancer.” Clinical Oncology (Royal
College of Radiologists) (Great Britain)) 24 (7)
(September): 474–87. doi:10.1016/j.clon.2012.05.006.
http://www.ncbi.nlm.nih.gov/pubmed/22770590.
Sisson, Stephen D, Dinesh S Rao, dan James
Demetroulakos. 2007. “Nasopharyngeal Carcinoma”.
Elsevier BV.
 ANGKA KETAHANAN HIDUP 3 TAHUN PASIEN KARSINOMA NASOFARINGS YANG MENDAPAT
NONCONCURRENT CHEMOTHERAPY 44
DI BAGIAN TELINGA HIDUNG TENGGOROK – KEPALA LEHER RSUP DR. SARDJITO PADA TAHUN
2008-2010
RYAN FERALDY HAROEN
Universitas Gadjah Mada, 2014 | Diunduh dari http://etd.repository.ugm.ac.id/

Taroeno-Hariadi, Kartika W, Ibnu Purwanto, dan Johan

Kurnianda. "Penatalaksanaan Kanker Nasofaring". Sub
Bagian Hematologi dan Onkologi Medis Bagian
Penyakit Dalam Fakultas Kedokteran Universitas
Gadjah Mada, RSUP Dr. Sardjito Yogyakarta.
Taylor 4th, SG, A K Murthy, dan J M Vannetzel. 1994.
“Randomized Comparison of Neoadjuvant Cisplatin and
Fluorouracil Infusion followed by Radiation versus
Concomitant Treatment in Advanced Head and Neck
Cancer”. Journal of Clinical Oncology; 12: 385-395.
Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K,
Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S,
Wernerus H, Björling L, dan Ponten F. 2010.
“Towards a knowledge-based Human Protein Atlas”.
Nat Biotechnol. 28(12):1248-50. PubMed: 21139605
DOI: 10.1038/nbt1210-1248.
Wei, William I, and Jonathan S T Sham. 2005.
“Nasopharyngeal Carcinoma” 365: 2041–2054.
Wildeman, Maarten A, Renske Fles, Camelia Herdini, Rai
S Indrasari, Andrew D Vincent, Maesadji
Tjokronagoro, Sharon Stoker, et al. 2013. “Primary
Treatment Results of Nasopharyngeal Carcinoma
( NPC ) in Yogyakarta , Indonesia” 8 (5): 1–6.
doi:10.1371/journal.pone.0063706.
Xu, Tingting, Guopei Zhu, Xiayun He, Hongmei Ying, and
Chaosu Hu. 2014. “A Phase III Randomized Study
Comparing Neoadjuvant Chemotherapy with Concurrent
Chemotherapy Combined with Radiotherapy for
Locoregionally Advanced Nasopharyngeal Carcinoma :
Updated Long-Term Survival Outcomes.” Oral Oncology
50 (2): 71–76. doi:10.1016/
j.oraloncology.2013.11.002.
Yusuf, Nuardi. 2013. “Angka Harapan Hidup 5 Tahun
Penderita Karsinoma Nasofarings yang Mendapat
Terapi Fotodinamik Di RS Dr. Sardjito” (Skripsi).
Universitas Gadjah Mada, Yogyakarta.
Zhang, Jia-Xing, Dong Qian, Feng-Wei Wang, Ding-Zhun
Liao, Jin-Huan Wei, Zhu-Ting Tong, Jia Fu, et al.
2013. “MicroRNA-29c Enhances the Sensitivities of
Human Nasopharyngeal Carcinoma to Cisplatin-Based
Chemotherapy and Radiotherapy.” Cancer Letters 329
(1) (February 1): 91–8.
doi:10.1016/j.canlet.2012.10.033.
http://www.ncbi.nlm.nih.gov/pubmed/23142283.
Zong YS, Zhang CQ, Zhang F. 1993. “Infiltrating
lymphocytes and accessory cells in nasopharyngeal
carcinoma”. Jpn J Cancer Res 84(8):900-905.